Brought to you by 
SIDDCO, CellPath in cancer drug discovery deal
23 Aug 1999
Executive Summary
High throughput screeners CellPath Inc. will pair up with combinatorial chemistry company SIDDCO (Systems Integration Drug Discovery Company, Inc.) to search for a cancer therapeutic. Any discoveries will be shared between the two biotechs.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Molecular Diversity
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Alliance
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
SIDDCO, CellPath in cancer drug discovery deal
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice